United States securities and exchange commission logo

                           June 10, 2021

       Scott Dunbar
       Acting Chief Executive Officer
       Second Sight Medical Products, Inc.
       13170 Telfair Ave
       Sylmar, California 91342

                                                        Re: Second Sight
Medical Products, Inc.
Statement on Form S-3
                                                            Filed June 8, 2021
                                                            File No. 333-256904

       Dear Mr. Dunbar:

              This is to advise you that we have not reviewed and will not
review your registration

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Jane
Park at 202-551-7439 with any questions.


                           Division of Corporation Finance

                           Office of Life Sciences
       cc:                                              Aaron Grunfeld, Esq.